The DOI matches its Crossref record; 826 of the 826 references it cites were found in a registry or an index.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
Open accessAbstract
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line treatments for these disorders are selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and the calcium channel modulator pregabalin. Tricyclic antidepressants (TCAs) are equally effective for some disorders, but many are less well tolerated than the SSRIs/SNRIs. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of substance abuse disorders. Potential treatment options for patients unresponsive to standard treatments are described in this overview. Although these guidelines focus on medications, non-pharmacological were also considered. Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
The development of a Clinician-Administered PTSD Scale
Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., & Keane, T. M. (1995) · Journal of Traumatic Stress · doi:10.1002/jts.2490080106 · Cited by 5,024
(1985) · Cited by 2,882
Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.629 · Cited by 2,695 · cited 1×
“Patients with anxiety disorders are frequent users of emergency medical services (Klerman et al. 1991; Wang et al. 2005), are at a high risk for suicide attempts (Weissman et al.”
BackgroundLiebowitz, M. R. (2015) · Modern Trends in Pharmacopsychiatry · doi:10.1159/000414022 · Cited by 2,266
Regier, D. A. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820140007001 · Cited by 1,999
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
Wittchen, H.-U., & Jacobi, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.012 · Cited by 1,503
Foa, E. B., Rothbaum, B. O., Riggs, D. S., & Murdock, T. B. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.5.715 · Cited by 1,444 · cited 1×
“In some studies CBT was superior to a wait list control, but not more effective than a psychological placebo (Foa et al. 1991; McDonagh et al. 2005; Neuner et al. 2004).”
BackgroundA double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Resick, P. A., Nishith, P., Weaver, T. L., Astin, M. C., & Feuer, C. A. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.4.867 · Cited by 1,294
False Suffocation Alarms, Spontaneous Panics, and Related Conditions: An Integrative Hypothesis
Klein, D. F. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820160076009 · Cited by 1,130
Cloitre, M., Koenen, K. C., Cohen, L. R., & Han, H. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.5.1067 · Cited by 1,097
Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
Ressler, K. J., & Mayberg, H. S. (2007) · Nature Neuroscience · doi:10.1038/nn1944 · Cited by 1,007
Neuroanatomical Hypothesis of Panic Disorder, Revised
Gorman, J. M., Kent, J. M., Sullivan, G. M., & Coplan, J. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.493 · Cited by 1,004
Marks, I. M. (1987) · Cited by 978
Kennedy, C. O. (1971) · British Homeopathic Journal · doi:10.1016/s0007-0785(71)80027-3 · Cited by 974
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Delineation of two drug-responsive anxiety syndromes
Klein, D. F. (1964) · Psychopharmacologia · doi:10.1007/bf02193476 · Cited by 898
Nuttin, B., Cosyns, P., Demeulemeester, H., Gybels, J., & Meyerson, B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02376-4 · Cited by 854
Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder
Greenberg, B. D., Malone, D. A., Friehs, G. M., Rezai, A. R., Kubu, C. S., Malloy, P. F., Salloway, S. P., Okun, M. S., Goodman, W. K., & Rasmussen, S. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301165 · Cited by 829
Narrow, W. E., Rae, D. S., Robins, L. N., & Regier, D. A. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.2.115 · Cited by 813
Foa, E. B., Dancu, C. V., Hembree, E. A., Jaycox, L. H., Meadows, E. A., & Street, G. P. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.67.2.194 · Cited by 808
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789
Borkovec, T. D., & Costello, E. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.4.611 · Cited by 756
Generalized anxiety disorder: prevalence, burden, and cost to society
Wittchen, H.-U. (2002) · Depression and Anxiety · doi:10.1002/da.10065 · Cited by 733
Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms
Sheehan, D. V. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140053006 · Cited by 729
(1997) · Research Explorer (The University of Manchester) · Cited by 714
Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., & Farfel, G. M. (2000) · JAMA · doi:10.1001/jama.283.14.1837 · Cited by 690
Clark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P., & Gelder, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.759 · Cited by 673 · cited 2×
“One study showed superiority of CBT, but the patients in the CBT group were allowed to use benzodiazepines, making the results difficult to interpret (Clark et al. 1994).”
BackgroundNeuner, F., Schauer, M., Klaschik, C., Karunakara, U., & Elbert, T. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.579 · Cited by 644 · cited 1×
“In some studies CBT was superior to a wait list control, but not more effective than a psychological placebo (Foa et al. 1991; McDonagh et al. 2005; Neuner et al. 2004).”
BackgroundSingle session debriefing after psychological trauma: a meta-analysis
van Emmerik, A. A., Kamphuis, J. H., Hulsbosch, A. M., & Emmelkamp, P. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09897-5 · Cited by 644
Westen, D., & Morrison, K. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.875 · Cited by 635 · cited 1×
“A number of meta-analyses have led to contradictory results regarding the efficacy of the psychological and pharmacological treatment of anxiety disorders (Clum et al. 1993; Cox et al. 1992a,b; Fedoroff and Taylor 2001; Foa 2000; Furukawa et al. 2006; Gould et al. 1997; Mattick et al. 1990; Mitte 2005; van Balkom et a…”
ResultBloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V, Bracken, M. B., & Leckman, J. F. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001823 · Cited by 635
A 40-Year Follow-up of Patients With Obsessive-compulsive Disorder
Skoog, G., & Skoog, I. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.2.121 · Cited by 632
Behavioral treatment of panic disorder
Barlow, D. H., Craske, M. G., Cerny, J. A., & Klosko, J. S. (1989) · Behavior Therapy · doi:10.1016/s0005-7894(89)80073-5 · Cited by 627
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Self-citationA Meta-Analytic Review of Adult Cognitive-Behavioral Treatment Outcome Across the Anxiety Disorders
Norton, P. J., & Price, E. C. (2007) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000253843.70149.9a · Cited by 612
Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radant, A., Thompson, C. E., Dobie, D. J., Hoff, D., Rein, R. J., Straits-Tröster, K., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.371 · Cited by 607
Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Erkens, J. A., Herings, R. M. C., & Mann, J. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030454 · Cited by 605
Suicidal Ideation and Suicide Attempts in Panic Disorder and Attacks
Weissman, M. M., Klerman, G. L., Markowitz, J. S., & Ouellette, R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911023211801 · Cited by 604
Clark, D. M., Ehlers, A., Hackmann, A., McManus, F., Fennell, M., Grey, N., Waddington, L., & Wild, J. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.3.568 · Cited by 603
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441703 · Cited by 588
Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia: 12-Week Outcome
Heimberg, R. G., Liebowitz, M. R., Hope, D. A., Schneier, F. R., Holt, C. S., Welkowitz, L. A., Juster, H. R., Campeas, R., Bruch, M. A., Cloitre, M., et al. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1133 · Cited by 585
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571
Frasure-Smith, N., & Lespérance, F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.4 · Cited by 571 · cited 2×
“Such anxiety disorders are believed to compound the management and the prognosis of chronic obstructive pulmonary disease (Brenes 2003), coronary artery disease or myocardial infarcation (Bankier et al. 2004; Frasure-Smith and Lesperance 2008; Shen et al. 2008), diabetes mellitus (Anderson et al.”
BackgroundMcDougle, C. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040046006 · Cited by 570
Sturm, V., Lenartz, D., Koulousakis, A., Treuer, H., Herholz, K., Klein, J. C., & Klosterkötter, J. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.09.003 · Cited by 567
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Taylor, S., Thordarson, D. S., Maxfield, L., Fedoroff, I. C., Lovell, K., & Ogrodniczuk, J. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.2.330 · Cited by 562
Clark, D. M., Ehlers, A., McManus, F., Hackmann, A., Fennell, M., Campbell, H., Flower, T., Davenport, C., & Louis, B. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.6.1058 · Cited by 561
Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560 · cited 1×
“In social anxiety disorder, augmentation of exposure therapy with d-cycloserine was successful according to two studies (Guastella et al. 2008; Hofmann et al. 2006).”
BackgroundSartorius, N., Üstün, T. B., Lecrubier, Y., & Wittchen, H.-U. (1996) · British Journal of Psychiatry · doi:10.1192/s0007125000298395 · Cited by 541
Implosive (flooding) therapy reduces symptoms of PTSD in Vietnam combat veterans
Keane, T. M., Fairbank, J. A., Caddell, J. M., & Zimering, R. T. (1989) · Behavior Therapy · doi:10.1016/s0005-7894(89)80072-3 · Cited by 541
Spence, S. H., Donovan, C., & Brechman‐Toussaint, M. (2000) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00659 · Cited by 527 · cited 1×
“In children and adolescents with SAD, CBT was more effective than a wait-list control condition in two studies (Baer and Garland 2005; Spence et al. 2000), while another study did not find lasting effects (Hayward et al.”
ResultDeep brain stimulation for refractory obsessive-compulsive disorder
Abelson, J. L., Curtis, G. C., Sagher, O., Albucher, R. C., Harrigan, M., Taylor, S. F., Martis, B., & Giordani, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.042 · Cited by 522
Pyeritz, R. E. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.481 · Cited by 515
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy
Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510
Weslen, D., & Morrison, K. (2002) · PsycEXTRA Dataset · doi:10.1037/e323162004-001 · Cited by 509
Greist, J. H. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130053006 · Cited by 500
Cognitive behavioral group treatment for social phobia: Comparison with a credible placebo control
Heimberg, R. G., Dodge, C. S., Hope, D. A., Kennedy, C. R., Zollo, L. J., & Becker, R. E. (1990) · Cognitive Therapy and Research · doi:10.1007/bf01173521 · Cited by 500
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma
Vaiva, G., Ducrocq, F., Jezequel, K., Averland, B., Lestavel, P., Brunet, A., & Marmar, C. R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00412-8 · Cited by 499
Clomipramine Treatment of Obsessive-Compulsive Disorder: I. A Controlled Clinical Trial
Thorén, P. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780240079009 · Cited by 497
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495
Abramowitz, J. S. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.1.44 · Cited by 490 · cited 1×
“As the available research evidence is not conclusive, opinions differ as to whether clomipramine has greater anti-obsessional efficacy than do the SSRIs (Abramowitz 1997; Bisserbe et al 1997; Greist et al 1995b; Piccinelli et al 1995; Pigott and Seay 1999; Todorov et al 2000).”
BackgroundLong-term Electrical Capsular Stimulation in Patients with Obsessive-Compulsive Disorder
Nuttin, B. J., Gabriëls, L. A., Cosyns, P. R., Meyerson, B. A., Andréewitch, S., Sunaert, S. G., Maes, A. F., Dupont, P. J., Gybels, J. M., Gielen, F., et al. (2003) · Neurosurgery · doi:10.1227/01.neu.0000064565.49299.9a · Cited by 487
Marks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478 · cited 4×
“In only one of six panic disorder studies, a longerlasting effect of CBT could be demonstrated (Marks et al. 1993).”
BackgroundResultInfluentialMayou, R. A., Ehlers, A., & Hobbs, M. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.6.589 · Cited by 475
Davidson, J. R. T., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.485 · Cited by 470
March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., Cutler, N. R., Dominguez, R., Ferguson, J., Muller, B., et al. (1998) · JAMA · doi:10.1001/jama.280.20.1752 · Cited by 469
Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament, M. F. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330057007 · Cited by 466 · cited 1×
“Clomipramine efficacy could also be demonstrated in DBPC studies in children and adolescents with OCD (DeVeaugh-Geiss et al. 1992; Flament et al. 1985)(A).”
Background(1998) · PubMed · Cited by 460
A Review of the Efficacy of Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder
Pigott, T. A., & Seay, S. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0206 · Cited by 454
Randomised controlled trial of psychological debriefing for victims of acute burn trauma
Bisson, J. I., Jenkins, P. L., Alexander, J., & Bannister, C. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.1.78 · Cited by 454
Clomipramine and Exposure for Obsessive-Compulsive Rituals: 1
Marks, I. M., Stern, R. S., Mawson, D., Cobb, J., & McDonald, R. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.1.1 · Cited by 448
Ladouceur, R., Dugas, M. J., Freeston, M. H., Léger, E., Gagnon, F., & Thibodeau, N. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.6.957 · Cited by 446 · cited 1×
“A number of studies showed superiority of CBT to a waiting list group (Barlow et al. 1992; Butler et al. 1991; Dugas et al. 2003; Ladouceur et al. 2000; Lindsay et al. 1987; Mohlman et al. 2003).”
BackgroundNulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Pace-Asciak, P., Shuhaiber, S., & Koren, G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1889 · Cited by 441
Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis.
Gould, R. A., Buckminster, S., Pollack, M. H., Otto, M. W., & Yap, L. (1997) · Clinical Psychology: Science and Practice · doi:10.1111/j.1468-2850.1997.tb00123.x · Cited by 438
Brief psychotherapy for posttraumatic stress disorders.
Brom, D., Kleber, R. J., & Defares, P. B. (1989) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.57.5.607 · Cited by 438
Efficacy and Safety of Paroxetine Treatment for Chronic PTSD: A Fixed-Dose, Placebo-Controlled Study
Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1982 · Cited by 432
Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant
Iqbal, M. M., Sobhan, T., & Ryals, T. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.39 · Cited by 427
Suicide Risk During Antidepressant Treatment
Simon, G. E., Savarino, J., Operskalski, B., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.41 · Cited by 424
Zohar, J., & Insel, T. R. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90199-5 · Cited by 416
Self-citationFluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placeboin Generalized Social Phobia
Davidson, J. R. T., Foa, E. B., Huppert, J. D., Keefe, F. J., Franklin, M. E., Compton, J. S., Zhao, N., Connor, K. M., Lynch, T. R., & Gadde, K. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.10.1005 · Cited by 415
Rickels, K. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820230054005 · Cited by 412
Fluoxetine in post‐traumatic stress disorder
Davidson, J., Roth, S., & Newman, E. (1991) · Journal of Traumatic Stress · doi:10.1002/jts.2490040309 · Cited by 412
McDonagh, A., Friedman, M., McHugo, G., Ford, J., Sengupta, A., Mueser, K., Demment, C. C., Fournier, D., Schnurr, P. P., & Descamps, M. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.3.515 · Cited by 404
RIDDLE, M. A., REEVE, E. A., YARYURA-TOBIAS, J. A., YANG, H. M., CLAGHORN, J. L., GAFFNEY, G., GREIST, J. H., HOLLAND, D., MCCONVILLE, B. J., PIGOTT, T., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00017 · Cited by 402
van der Kolk, B. A., Spinazzola, J., Blaustein, M. E., Hopper, J. W., Hopper, E. K., Korn, D. L., & Simpson, W. B. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0105 · Cited by 399
Whittal, M. L., Thordarson, D. S., & McLean, P. D. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.11.012 · Cited by 397
Psychological and Pharmacological Treatments of Social Phobia: A Meta-Analysis
Fedoroff, I. C., & Taylor, S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00011 · Cited by 396 · cited 1×
“A number of meta-analyses have led to contradictory results regarding the efficacy of the psychological and pharmacological treatment of anxiety disorders (Clum et al. 1993; Cox et al. 1992a,b; Fedoroff and Taylor 2001; Foa 2000; Furukawa et al. 2006; Gould et al. 1997; Mattick et al. 1990; Mitte 2005; van Balkom et a…”
ResultMitte, K. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.05.003 · Cited by 396
Treatment of Social Phobia With Gabapentin: A Placebo-Controlled Study
Pande, A. C., Davidson, J. R. T., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H., Greist, J. H., & Sutherland, S. M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00010 · Cited by 395
Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder: A Double-blind Comparison With Placebo
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010038006 · Cited by 390
Clomipramine in the Treatment of Patients With Obsessive-Compulsive Disorder
(1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320054008 · Cited by 388
Fluoxetine for the Treatment of Childhood Anxiety Disorders
BIRMAHER, B., AXELSON, D. A., MONK, K., KALAS, C., CLARK, D. B., EHMANN, M., BRIDGE, J., HEO, J., & BRENT, D. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000037049.04952.9f · Cited by 385
D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder
Kushner, M. G., Kim, S. W., Donahue, C., Thuras, P., Adson, D., Kotlyar, M., McCabe, J., Peterson, J., & Foa, E. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.020 · Cited by 384
Psychological treatment of panic: Work in progress on outcome, active ingredients, and follow-up
Margraf, J., Barlow, D. H., Clark, D. M., & Telch, M. J. (1993) · Behaviour Research and Therapy · doi:10.1016/0005-7967(93)90036-t · Cited by 377 · cited 1×
“Cognitive-behavioural techniques were superior to waiting list control condition in a number of studies in panic disorder and/or agoraphobia (Barlow et al. 1989; Gould and Clum 1995; Klosko et al. 1990; Lidren et al. 1994; Margraf et al. 1993; Swinson et al. 1995; Telch et al. 1993, 1995; Williams and Falbo 1996), wit…”
MethodLeonard, H. L. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810120030006 · Cited by 369
Butler, G., Fennell, M., Robson, P., & Gelder, M. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.167 · Cited by 365 · cited 2×
“A number of studies showed superiority of CBT to a waiting list group (Barlow et al. 1992; Butler et al. 1991; Dugas et al. 2003; Ladouceur et al. 2000; Lindsay et al. 1987; Mohlman et al. 2003).”
BackgroundAouizerate, B., Cuny, E., Martin-Guehl, C., Guehl, D., Amieva, H., Benazzouz, A., Fabrigoule, C., Allard, M., Rougier, A., Bioulac, B., et al. (2004) · Journal of Neurosurgery · doi:10.3171/jns.2004.101.4.0682 · Cited by 359
Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358
Dougherty, D. D., Baer, L., Cosgrove, G. R., Cassem, E. H., Price, B. H., Nierenberg, A. A., Jenike, M. A., & Rauch, S. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.269 · Cited by 354
Fluoxetine in post-traumatic stress disorder: Randomised, double-blind study
Connor, K. M., Sutherland, S. M., Tupler, L. A., Malik, M. L., Jonathan, R., & Davidson, T. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.17 · Cited by 353
Treatment of Posttraumatic Stress Disorder With Amitriptyline and Placebo
Davidson, J. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150059010 · Cited by 350
Cognitive therapy and exposure in vivo in the treatment of obsessive–compulsive disorder
Van Oppen, P., De Haan, E., Van Balkom, A. J. L. M., Spinhoven, P., Hoogduin, K., & Van Dyck, R. (1995) · Behaviour Research and Therapy · doi:10.1016/0005-7967(94)00052-l · Cited by 350
DEVEAUGH-GEISS, J., MOROZ, G., BIEDERMAN, J., CANTWELL, D., FONTAINE, R., GREIST, J. H., REICHLER, R., KATZ, R., & LANDAU, P. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00008 · Cited by 349
Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W., & Gergel, I. (1998) · JAMA · doi:10.1001/jama.280.8.708 · Cited by 348
Cognitive mediation of treatment change in social phobia
Hofmann, S. G. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.3.392 · Cited by 348
Stein, M. B., Kline, N. A., & Matloff, J. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1777 · Cited by 347
Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review
Mikkelsen, R. L., Middelboe, T., Pisinger, C., & Stage, K. B. (2004) · Nordic Journal of Psychiatry · doi:10.1080/08039480310000824 · Cited by 345
RIDDLE, M. A., SCAHILL, L., KING, R. A., HARDIN, M. T., ANDERSON, G. M., ORT, S. I., SMITH, J. C., LECKMAN, J. F., & COHEN, D. J. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199211000-00011 · Cited by 345
Treatment of Phobias: I. Comparison of Imipramine Hydrochloride and Placebo
Zitrin, C. M. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790020019002 · Cited by 342
Use of benzodiazepines in anxiety disorders
Wood, A. J. J., Shader, R. I., & Greenblatt, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281907 · Cited by 341
Anxiety and chronic obstructive pulmonary disease: prevalence, impact and treatment
Brenes, G. A. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000097339.75789.81 · Cited by 339
Schelling, G., Briegel, J., Roozendaal, B., Stoll, C., Rothenhäusler, H.-B., & Kapfhammer, H.-P. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01270-7 · Cited by 337
Mantovani, A., Lisanby, S. H., Pieraccini, F., Ulivelli, M., Castrogiovanni, P., & Rossi, S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005729 · Cited by 334
Cohen, H., Kaplan, Z., Kotler, M., Kouperman, I., Moisa, R., & Grisaru, N. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.515 · Cited by 334
Pharmacotherapy of Social Phobia: A Controlled Study with Moclobemide and Phenelzine
Versiani, M., Nardi, A. E., Mundim, F. D., Alves, A. B., Liebowitz, M. R., & Amrein, R. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.3.353 · Cited by 333
Cognitive versus behavior therapy in the group treatment of obsessive–compulsive disorder
McLean, P. D., Whittal, M. L., Thordarson, D. S., Taylor, S., Söchting, I., Koch, W. J., Paterson, R., & Anderson, K. W. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.2.205 · Cited by 332 · cited 1×
“1995), whereas CBT and ERP were found to be equal in other studies (McLean et al. 2001; Vogel and Gotestam 2004; Whittal et al. 2005).”
ResultLong-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Rickels, K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220015002 · Cited by 332
Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine
Zitrin, C. M. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140065007 · Cited by 332
Dugas, M. J., Ladouceur, R., Léger, E., Freeston, M. H., Langolis, F., Provencher, M. D., & Boisvert, J.-M. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.821 · Cited by 331
Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants
Weissman, A. M., Levy, B. T., Hartz, A. J., Bentler, S., Donohue, M., Ellingrod, V. L., & Wisner, K. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1066 · Cited by 329
Anxiety and Poor Glycemic Control: A Meta-Analytic Review of the Literature
Anderson, R. J., Grigsby, A. B., Freedland, K. E., De Groot, M., McGill, J. B., Clouse, R. E., & Lustman, P. J. (2002) · The International Journal of Psychiatry in Medicine · doi:10.2190/klgd-4h8d-4ryl-twq8 · Cited by 328
Guastella, A. J., Richardson, R., Lovibond, P. F., Rapee, R. M., Gaston, J. E., Mitchell, P., & Dadds, M. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.011 · Cited by 326
Bryant, R. A., Moulds, M. L., Guthrie, R. M., Dang, S. T., & Nixon, R. D. V. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.4.706 · Cited by 325 · cited 1×
“Superiority to a psychological placebo was found in a number of studies (Blanchard et al. 2003; Bryant et al. 2003; Echeburua et al. 1997; Marks et al. 1998; Power et al. 2002).”
BackgroundLow Dopamine D2 Receptor Binding Potential in Social Phobia
Schneier, F. R., Liebowitz, M. R., Abi-Dargham, A., Zea-Ponce, Y., Lin, S.-H., & Laruelle, M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.457 · Cited by 325
Tucker, P., Zaninelli, R., Yehuda, R., Ruggiero, L., Dillingham, K., & Pitts, C. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1105 · Cited by 324
Treatment of recent trauma survivors with benzodiazepines: a prospective study.
Gelpin, E., Bonne, O. B., Peri, T., Brandes, D., & Shalev, A. Y. (1996) · PubMed · Cited by 322
Greist, J. H., Marks, I. M., Baer, L., Kobak, K. A., Wenzel, K. W., Hirsch, M. J., Mantle, J. M., & Clary, C. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0209 · Cited by 321
Rynn, M. A., Siqueland, L., & Rickels, K. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2008 · Cited by 321
GELLER, D. A., HOOG, S. L., HEILIGENSTEIN, J. H., RICARDI, R. K., TAMURA, R., KLUSZYNSKI, S., JACOBSON, J. G., & FLUOXETINE PEDIATRIC OCD STUDY TEAM (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00011 · Cited by 320
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Ballenger, J. C., Davidson, J. R., Lecrubier, Y., Nutt, D. J., Foa, E. B., Kessler, R. C., McFARLANE, A. C., & Shalev, A. Y. (2000) · PubMed · Cited by 316
Ironson, G., Freund, B., Strauss, J. L., & Williams, J. (2002) · Journal of Clinical Psychology · doi:10.1002/jclp.1132 · Cited by 316
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.867 · Cited by 315
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
Coric, V., Taskiran, S., Pittenger, C., Wasylink, S., Mathalon, D. H., Valentine, G., Saksa, J., Wu, Y.-T., Gueorguieva, R., Sanacora, G., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.043 · Cited by 314
Clinical Handbook of Psychotropic Drugs
(2015) · Hogrefe Publishing eBooks · doi:10.1027/00474-000 · Cited by 314
Tollefson, G. D. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070051010 · Cited by 314
Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial
Pande, A. C., Crockatt, J. G., Feltner, D. E., Janney, C. A., Smith, W. T., Weisler, R., Londborg, P. D., Bielski, R. J., Zimbroff, D. L., Davidson, J. R. T., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.533 · Cited by 314
Buspirone and diazepam in anxiety: a controlled study.
Rickels, K., Weisman, K., Norstad, N., Singer, M. L., Stoltz, D., Brown, A. S., & Danton, J. (1982) · PubMed · Cited by 308
Neurobiology of Mental Illness.
O'Donnell, P. (2000) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200006000-00013 · Cited by 305
Davidson, J. R. T., DuPont, R. L., Hedges, D., & Haskins, J. T. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0805 · Cited by 303
Blanchard, E. B., Hickling, E. J., Devineni, T., Veazey, C. H., Galovski, T. E., Mundy, E., Malta, L. S., & Buckley, T. C. (2003) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(01)00131-0 · Cited by 300
Gabriëls, L., Cosyns, P., Nuttin, B., Demeulemeester, H., & Gybels, J. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00066.x · Cited by 298
Gelenberg, A. J., Lydiard, R. B., Rudolph, R. L., Aguiar, L., Haskins, J. T., & Salinas, E. (2000) · JAMA · doi:10.1001/jama.283.23.3082 · Cited by 296
Propranolol Treatment for Childhood Posttraumatic Stress Disorder, Acute Type: A Pilot Study
Famularo, R. (1988) · American Journal of Diseases of Children · doi:10.1001/archpedi.1988.02150110122036 · Cited by 296
Devilly, G. J., & Spence, S. H. (1999) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(98)00044-9 · Cited by 294
DEN BOER, J. A., & WESTENBERG, H. G. M. (1988) · International Clinical Psychopharmacology · doi:10.1097/00004850-198801000-00005 · Cited by 288
Hartford, J., Kornstein, S., Liebowitz, M., Pigott, T., Russell, J., Detke, M., Walker, D., Ball, S., Dunayevich, E., Dinkel, J., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32807fb1b2 · Cited by 286
Panic attacks in the community. Social morbidity and health care utilization
Klerman, G. L. (1991) · JAMA · doi:10.1001/jama.265.6.742 · Cited by 286
Delivery outcome after the use of antidepressants in early pregnancy
Ericson, A., Källén, B., & Wiholm, B.-E. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050664 · Cited by 284
Efficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review
Piccinelli, M., Pini, S., Bellantuono, C., & Wilkinson, G. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.4.424 · Cited by 282
Rickels, K., Pollack, M. H., Feltner, D. E., Lydiard, R. B., Zimbroff, D. L., Bielski, R. J., Tobias, K., Brock, J. D., Zornberg, G. L., & Pande, A. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.1022 · Cited by 280
Hohagen, F., Winkelmann, G., Rasche-Räuchle, H., Hand, I., König, A., Münchau, N., Hiss, H., Geiger-Kabisch, C., Käppler, C., Schramm, P., et al. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297924 · Cited by 280
Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder
Pande, A. C., Pollack, M. H., Crockatt, J., Greiner, M., Chouinard, G., Lydiard, R. B., Taylor, C. B., Dager, S. R., & Shiovitz, T. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00011 · Cited by 279
Paroxetine versus Clomipramine in the Treatment of Obsessive–Compulsive Disorder
Zohar, J., Judge, R., & Ocd Paroxetine Study Investigators (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.468 · Cited by 272
Self-citationNeuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.5.652 · Cited by 271
A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder
Hertzberg, M. A., Butterfield, M. I., Feldman, M. E., Beckham, J. C., Sutherland, S. M., Connor, K. M., & Davidson, J. R. T. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00011-6 · Cited by 271
Källén, B. A. J., & Otterblad Olausson, P. (2007) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20327 · Cited by 270
van Vliet, I. M., den Boer, J. A., & Westenberg, H. G. M. (1994) · Psychopharmacology · doi:10.1007/bf02244762 · Cited by 269
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guidelines for Schizophrenia, Falkai, P., Wobrock, T., Lieberman, J., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030090 · Cited by 269
Self-citationGroup cognitive-behavioral treatment of panic disorder
Telch, M. J., Lucas, J. A., Schmidt, N. B., Hanna, H. H., Jaimez, T. L., & Lucas, R. A. (1993) · Behaviour Research and Therapy · doi:10.1016/0005-7967(93)90026-q · Cited by 265
Treatment of Social Phobia With Clonazepam and Placebo
DAVIDSON, J. R. T., POTTS, N., RICHICHI, E., KRISHNAN, R., FORD, S. M., SMITH, R., & WILSON, W. H. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312000-00008 · Cited by 265
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.10.1485 · Cited by 263
Carlbring, P., Bohman, S., Brunt, S., Buhrman, M., Westling, B. E., Ekselius, L., & Andersson, G. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2119 · Cited by 262
Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study
Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.3.374 · Cited by 261
Feltner, D. E., Crockatt, J. G., Dubovsky, S. J., Cohn, C. K., Shrivastava, R. K., Targum, S. D., Liu-Dumaw, M., Carter, C. M., & Pande, A. C. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084032.22282.ff · Cited by 260
Cingulotomy for Refractory Obsessive Compulsive Disorder: A Long-term Follow-up of 33 Patients
Jenike, M. A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810300060009 · Cited by 259
A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.10.1289 · Cited by 259
Behavioral treatment of panic disorder: A two-year follow-up
Craske, M. G., Brown, T. A., & Barlow, D. H. (1991) · Behavior Therapy · doi:10.1016/s0005-7894(05)80367-3 · Cited by 258
Health economics and cost implications of anxiety and other mental disorders in the United States
Rice, D. P., & Miller, L. S. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000293458 · Cited by 258
Carlson, J. G., Chemtob, C. M., Rusnak, K., Hedlund, N. L., & Muraoka, M. Y. (1998) · Journal of Traumatic Stress · doi:10.1023/a:1024448814268 · Cited by 257
Clomipramine, self-exposure and therapist-aided exposure for obsessive–compulsive rituals
Marks, I. M., Lelliott, P., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., & Kasvikis, Y. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.152.4.522 · Cited by 255
Rickels, K., Pollack, M. H., Sheehan, D. V., & Haskins, J. T. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.968 · Cited by 252
Hobbs, M., Mayou, R., Harrison, B., & Worlock, P. (1996) · BMJ · doi:10.1136/bmj.313.7070.1438 · Cited by 251
Baldwin, D., Bobes, J., Stein, D. J., Scharwächter, I., & Faure, M. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.2.120 · Cited by 251
VAN BALKOM, A. J. L. M., DE HAAN, E., VAN OPPEN, P., SPINHOVEN, P., HOOGDUIN, K. A. L., & VAN DYCK, R. (1998) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199808000-00007 · Cited by 250
Stein, M. B., Kerridge, C., Dimsdale, J. E., & Hoyt, D. B. (2007) · Journal of Traumatic Stress · doi:10.1002/jts.20270 · Cited by 249
A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder
Black, D. W. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130046008 · Cited by 249
Denys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248
Pharmacologic Treatment of Depression During Pregnancy
Wisner, K. L. (1999) · JAMA · doi:10.1001/jama.282.13.1264 · Cited by 247
Cognitive-behavioral treatment of late-life generalized anxiety disorder
Stanley, M. A., Beck, J. G., Novy, D. M., Averill, P. M., Swann, A. C., Diefenbach, G. J., & Hopko, D. R. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.2.309 · Cited by 247 · cited 1×
“Moreover, comparisons with a ‘‘psychological placebo’’, a pill placebo or comparable control group conditions showed that CBT has not only unspecific psychotherapy effects, but also specific ingredients (Borkovec et al. 1987; Borkovec and Costello 1993; Linden et al. 2005; Power et al. 1990; Stanley et al. 2003).”
ResultPollack, M. H., Zaninelli, R., Goddard, A., McCafferty, J. P., Bellew, K. M., Burnham, D. B., & Iyengar, M. K. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0508 · Cited by 246
Psychiatric comorbidity following traumatic brain injury
Rogers, J. M., & Read, C. A. (2007) · Brain Injury · doi:10.1080/02699050701765700 · Cited by 246
ROTHBAUM, B. O. (1997) · PubMed · Cited by 246
Controlled trial of exposure and response prevention in obsessive–compulsive disorder
Lindsay, M., Crino, R., & Andrews, G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.2.135 · Cited by 245 · cited 1×
“In another study, ERP was superior to ‘‘anxiety management’’ as a control group, but only 18 patients were included in the study (Lindsay et al. 1997).”
Ninan, P. T., Koran, L. M., Kiev, A., Davidson, J. R. T., Rasmussen, S. A., Zajecka, J. M., Robinson, D. G., Crits-Christoph, P., Mandel, F. S., & Austin, C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0103 · Cited by 245
Clomipramine in obsessive-compulsive disorder
Katz, R. J., DeVeaugh-Geiss, J., & Landau, P. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90408-t · Cited by 245
A comparison of alprazolam and behavior therapy in treatment of panic disorder.
Klosko, J. S., Barlow, D. H., Tassinari, R., & Cerny, J. A. (1990) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.58.1.77 · Cited by 244
Research works printed but not linked: 116
- Altshuler LL, 2001, Postgrad Med, 1
- Amore M, 1999, Hum Psychopharmacol Clin Exp, 14, 435, 10.1002/(SICI)1099-1077(199908)14:6<435::AID-HUP109>3.0.CO;2-B · doi:10.1002/(sici)1099-1077(199908)14:6<435::aid-hup109>3.0.co;2-b
- Bakish D, 1996, Psychopharmacol Bull, 32, 135
- Ballenger JC, 2001, J Clin Psychiatry, 62, 53
- Bandelow B, 2004, Br J Psychiatry, 184, 271, 10.1192/bjp.184.3.271 · DOI
- Bandelow B, 2002, Eur Neuropsychopharmacol, 12, S364, 10.1016/S0924-977X(02)80585-5 · doi:10.1016/s0924-977x(02)80585-5
- Bradwejn J, 1993, Can J Psychiatry, 38, S109
- Braun P, 1990, J Clin Psychiatry, 51, 236
- Bystritsky A, 2008, Psychopharmacol Bull, 41, 46
- 10.3109/10401239909147053 · doi:10.3109/10401239909147053
- Chao IL, 2004, Pharmacopsychiatry, 37, 239, 10.1055/s-2004-832600 · DOI
- Charney DS, 1989, J Clin Psychiatry, 50, 418
- Charney DS, 1986, J Clin Psychiatry, 47, 580
- Chouinard G, 1990, Psychopharmacol Bull, 26, 279
- 10.3109/10401230490281609 · doi:10.3109/10401230490281609
- Davis LL, 2008, Psychopharmacol Bull, 41, 8
- DeVeaugh-Geiss J, 1989, Psychopharmacol Bull, 25, 36
- Dieleman GC, 2008, Tijdschr Psychiatr, 50, 43
- Dunner DL, 1986, J Clin Psychiatry, 47, 458
- Eriksson T, 2007, Int Clin Psychopharmacol, 22, 57
- Feighner JP, 1987, J Clin Psychiatry (Suppl), 48, 3
- Feighner JP, 1982, J Clin Psychiatry, 43, 103
- Feltner DE, 2003, J Clin Psychopharmacol, 23, 240
- Ferreri M, 1994, Encéphale, 20, 785
- 10.1037/0022-006X.65.6.1026 · doi:10.1037/0022-006x.65.6.1026
- Fesler FA, 1991, J Clin Psychiatry, 52, 361
- Foa EB, 2000, J Clin Psychiatry, 61, 43
- Frommberger U, 2004, Fortschr Neurol Psychiatr, 72, 411, 10.1055/s-2004-818455 · doi:10.1055/s-2004-818455
- Gelpin E, 1996, J Clin Psychiatry, 57, 390
- Gruber RP, 1971, Dis Nerv Syst, 32, 180
- Hamner MB, 2001, Ann Clin Psychiatry, 13, 141, 10.3109/10401230109148960 · DOI
- 10.3109/10401230009147096 · DOI · Paper page
- Hoehn-Saric R, 1988, J Clin Psychiatry, 49, 293
- Hoffart A, 1993, J Clin Psychiatry, 54, 481
- 10.1037/0022-006X.72.3.393 · DOI
- Hofmann SG, 2008, J Clin Psychiatry, e1
- Husain MM, 1993, Am J Psychiatry, 150, 1899
- Jenike MA, 1991, J Clin Psychiatry, 52, 13
- Khanna S, 1988, Convuls Ther, 4, 314
- Klerman GL, 199, Social Morbidity Health Care Utilization J, 265, 742
- Kocabasoglu N, 2004, Eur Neuropsychopharmacol, 14, S304, 10.1016/S0924-977X(04)80382-1 · doi:10.1016/s0924-977x(04)80382-1
- Koran LM, 2007, Am J Psychiatry, 164, 5
- Lee C, 2002, J Clin Psychol Psychother, 58, 1071
- Lenox-Smith AJ, 2003, Br J Gen Pract, 53, 772
- Li D, 2001, J Psychiatry Neurosci, 26, 190
- Lidren DM, 1994, J Consult Clin Psychol, 62, 865, 10.1037/0022-006X.62.4.865 · DOI · Paper page
- Liebowitz MR, 1988, J Clin Psychiatry, 49, 252
- 10.1002/(SICI)1520-6394(1999)10:3%3C89::AID-DA1%3E3.0.CO;2-5 · doi:10.1002/(sici)1520-6394(1999)10:3<89::aid-da1>3.0.co;2-5
- Livingston MG, 1994, Br J Hosp Med, 51, 281
- Lopes AC, 2008, Biol Psychiaty, 63, 131s, 10.1016/j.biopsych.2007.11.007 · doi:10.1016/j.biopsych.2007.11.007
- López-Ibor JJ, 1975, Neurological treatment in psychiatry, pain and epilepsy, 151
- Lum M, 1990, Biol Psychiatry :A, 27, 164
- Maletzky B, 1994, Convuls Ther, 10, 34
- Marazziti D, 1999, Am J Psychiatry, 156, 1834, 10.1176/ajp.156.11.1834-a · doi:10.1176/ajp.156.11.1834-a
- Marmar CR, 1996, J Clin Psychiatry, 57, 66
- Mavissakalian M, 1983, Psychopharmacol Bull, 19, 116
- Mavissakalian M, 1986, J Clin Psychol, 47, 117
- Meibach RC, 1987, J Clin Psychiatry, 48, 355
- Misri S, 2000, Can Family Phys, 46, 626
- Mohlman J, 2003, Am J Geriatr Psychiatry, 11, 24
- Montoya A, 2002, Neurosurgery, 50, 1043
- Munjack DJ, 1989, J Clin Psychopharmacol, 9, 22
- Munjack DJ, 1990, J Clin Psychiatry, 51, 35
- Nelson J, 1999, Can Soc Clin Pharmacol, 6, 69
- Neylan TC, 2006, Am J Psychiatry, 163, 2186, 10.1176/ajp.2006.163.12.2186 · doi:10.1176/ajp.2006.163.12.2186
- Nicolini H, 2008, Psychol Med, 1
- NIMH 1976. National Institute of Mental Health. 028 CGI. Clinical Global Impressions. In: Guy E, ECDEU Assessment manual for psychopharmacology. Revised edition. Rockville, MD: NIMH. p 217–222.
- Noyes R, 1996, J Clin Psychiatry, 57, 349
- Nutt DJ, 1998, J Clin Psychiatry, 59, 4
- Ontiveros A, 1992, J Psychiatry Neurosci, 17, 78
- Pastrana Jiménez JI, 2007, Actas Esp Psiquiatr, 35, 351
- Pigott TA, 1992, J Clin Psychopharmacol, 12, 11
- Pollack MH, 2003, Psychopharmacol Bull, 37, 53
- Pollack MH, 1994, J Clin Psychiatry, 55, 200
- Pollack MH, 1996, Psychopharmacol Bull, 32, 667
- Pollack MH, 1997, J Clin Psychiatry, 58, 19
- Pols H, 1993, Acta Psychiatr Belg, 93, 169
- Power KG, 1990, Br J Gen Pract, 40, 289
- Prasko J, 2006, Neuroendocrinol Lett, 27, 473
- Prasko J, 2006, Neuroendocrinol Lett, 27, 327
- 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
- Ravizza L, 1996, Psychopharmacol Bull, 32, 677
- 10.1037/0022-006X.70.4.86 · doi:10.1037/0022-006x.70.4.86
- Rickels K, 1982, J Clin Psychiatry, 43, 81
- Riddle MA, 1996, Psychopharmacol Bull, 32, 399
- Rizley R, 1986, Psychopharmacol Bull, 22, 167
- Rothbaum B, 1997, Bull Menninger Clinic, 61, 317
- Rothbaum BO, 2008, J Clin Psychiatry, e1
- Rück C, 2006, Capsulotomy in anxiety disorders [thesis]
- 10.1176/appi.ajp.164.2.290 · DOI
- 10.1002/da.20271 · DOI
- Sachdev P, 1995, J Nerv Ment Dis, 183, 408, 10.1097/00005053-199506000-00010 · doi:10.1097/00005053-199506000-00010
- 10.1345/aph.1C040 · doi:10.1345/aph.1c040 · Paper page
- Saxena S, 1996, J Clin Psychiatry, 57, 303
- Seedat S, 2004, J Clin Psychiatry, 65, 244
- Shader RI, 1993, New Engl J Med, 13, 1398
- Sharp DM, 1997, Br J Gen Pract, 47, 150
- Simon NM, 2003, Psychopharmacol Bull, 37, 66
- Simon NM, 2008, J Clin Psychiatry, e1
- Stein DJ, 1999, S Afr Med J, 89, 402
- 10.3109/10401230600948431 · doi:10.3109/10401230600948431
- Stein DJ, 2007, Eur Neuropsychophar17(Suppl, 4, S509, 10.1016/S0924-977X(07)70784-8 · doi:10.1016/s0924-977x(07)70784-8
- Strand M, 1990, J Clin Psychiatry (Suppl), 51, 40
- Telch MJ, 1995, J Consult Clin Psychol, 63, 823, 10.1037/0022-006X.63.5.823 · doi:10.1037/0022-006x.63.5.823
- Tesar GE, 1991, J Clin Psychiatry, 52, 69
- Tiffon L, 1994, J Clin Psychiatry, 55, 66
- Todorov C, 2000, Can J Psychiatry, 45, 257, 10.1177/070674370004500304 · doi:10.1177/070674370004500304
- Turner SM, 1994, J Consult Clin Psychol, 62, 350, 10.1037/0022-006X.62.2.350 · DOI · Paper page
- van Ameringen M, 1993, J Clin Psychiatry, 54, 27
- van der Kolk BA, 1994, J Clin Psychiatry, 55, 517
- Wetherell JL, 2003, J Consult Clin Psychol, 71, 31, 10.1037/0022-006X.71.1.31 · DOI · Paper page
- WHO, 1991, Clinical Descriptions and Diagnostic Guidelines
- Woodman CL, 1994, J Clin Psychiatry, 55, 134
- Worthington JJ, 1998, Psychopharmacol Bull, 34, 199
- Zitterl W, 1999, Wien Klin Wochenschr, 111, 439
- Zohar J, 2006, Obsessive-compulsive disorder and comorbidity, 79
Cited by
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079
Self-citationStein, D. J., Costa, D. L. C., Lochner, C., Miguel, E. C., Reddy, Y. C. J., Shavitt, R. G., van den Heuvel, O. A., & Simpson, H. B. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0102-3 · Cited by 895
Treatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Self-citationObsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
Self-citation
Metadata
- Authors
- Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., & WFSBP TASK FORCE ON TREATMENT GUIDE
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 9
- Issue
- 4
- Pages
- 248-312
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W1966065460
- Cited by
- 854
- References
- 826
- FWCI
- 73.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.